Hsp90 inhibitors enhance the antitumoral effect of osimertinib in parental and osimertinib-resistant non-small cell lung cancer cell lines
Open Access
- 1 August 2019
- journal article
- research article
- Published by AME Publishing Company in Translational Lung Cancer Research
- Vol. 8 (4) , 340-351